Centre Leon Berard: Carcinoma, Renal Cell trials

The registry lists 10 Carcinoma, Renal Cell studies with Centre Leon Berard as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 4Phase 3 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Axitinib +/- Pembrolizumab in First Line Treatment of mPRCCRecruitingNCT05096390Phase 2
• Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain MetastasesCompletedNCT03967522Phase 2
• BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)Status unknownNCT03628859
• Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted TherapiesTerminatedNCT03408652Phase 3
• Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell CarcinomaCompletedNCT02489695Phase 2
• Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid TumorsCompletedNCT01202032Phase 1
• Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell CarcinomaCompletedNCT00619268Phase 2
• Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney CancerCompletedNCT00416871Phase 3
• Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney CancerCompletedNCT00416429Phase 3
• Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate PrognosisCompletedNCT00291369Phase 3